Evidence map›Paper›PMID 35563667›Full record

ArticleInternational journal of molecular sciences2022

Comparison of the Biochemical Properties and Roles in the Xyloglucan-Rich Biomass Degradation of a GH74 Xyloglucanase and Its CBM-Deleted Variant from

Beibei Wang, Kaixiang Chen, Peiyu Zhang, Liangkun Long, Shaojun Ding

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 24 citations in OpenAlex.

  1. An acidophilic GH12 xyloglucanase fromFrontiers in nutrition · 2026
    Article
  2. Characterization of Xyloglucanase TpXEG12a fromInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Feasibility insights into the application ofFrontiers in microbiology · 2023
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Beibei WangJiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, China.
Kaixiang ChenJiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, China.
Peiyu ZhangJiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, China.
Liangkun LongJiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, China.
Shaojun DingJiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, China.ORCID 0000-0002-8359-9252
Nanjing Forestry University · CN

Funding

the National Natural Science Foundation of China 22178179
6 · The paper itself

Abstract

Xyloglucan is closely associated with cellulose and still retained with some modification in pretreated lignocellulose; however, its influence on lignocellulose biodegradation is less understood.

Indexed as

Glycoside HydrolasesXylansBiomassCelluloseDietary FiberGlucansHydrolysisSordarialesSubstrate SpecificityCelluloseDietary FiberGlucansGlycoside HydrolasesXylansxyloglucanxyloglucan endo(1-4)-beta-D-glucanasefamily 1 carbohydrate-binding module (CBM1)glycoside hydrolase family 74 (GH74) xyloglucanaselignocellulosic biomasssynergismThielavia terrestrisXyloglucan

Identifiers

PMID35563667
PMCPMC9103125
OpenAlexW4229450029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.